TABLE 5.
Sleep and respiratory data in sleep apnoeic males at baseline and after sham-continuous positive airway pressure (CPAP) and CPAP treatment phases
Baseline | Post-CPAP | Post-sham-CPAP | |
---|---|---|---|
Sleep latency min | 14.24± 1.58 | 11.70±1.38 | 11.50±1.46 |
WASO min | 112.97 ±10.28 | 79.23 ±10.28* | 103.11 ±8.65# |
TWT min | 127.20±10.63 | 90.93 ±10.99* | 114.61 ±8.88# |
Sleep time TST % | 73.59±2.19 | 81.14±2.28* | 76.19± 1.82# |
N1 % | 22.42± 1.88 | 14.67 ±1.32* | 19.23±1.78# |
N2 % | 56.28±2.82 | 60.82±2.21 | 60.38±2.17 |
SWS% | 6.83± 1.56 | 6.99 ±1.66 | 7.18±1.69 |
REM % | 14.47±1.61 | 15.18± 1.13 | 13.20±1.13 |
REM latency min | 109.28±14.63 | 95.69 ±12.86 | 110.20 ±12.62 |
AHI | 42.12±4.87 | 2.46 ±1.10* | 31.55±5.76# |
Minimum Sa,O2 | 81.18± 1.81 | 91.73 ±1.15* | 83.18±1.64# |
Data are presented as mean±SE. WASO: wake time after sleep onset; TWT: total wake time; TST: total sleep time; N1: stage 1 nonrapid eye movement (NREM) sleep; N2: stage 2 NREM sleep; SWS: slow wave sleep; REM: rapid eye movement; AHI: apnoea/hypopnoea index; Sa,O2: arterial oxygen stauration.
p<0.05 between baseline and post-CPAP treatment;
p<0.05 between CPAP and sham-CPAP.